Alan Minsk, J.D. is the Chair of Arnall Golden Gregory LLP's Food and Drug practice and Co-Chair of its Life Sciences industry team. He advises pharmaceutical, biologic, medical device, cosmetic and food companies on all legal and regulatory matters relating to the U.S. Food and Drug Administration.
Advances in AI offer promising opportunities to strengthen food manufacturers' internal compliance efforts with FDA requirements. While FDA has issued written guidances on AI, primarily for drug and medical device companies, its direct application to food safety is still evolving.
